On The Web![[search]](http://wwwcache.wral.com/presentation/v1/images/icons/16x12/search-form-icon.gif){kind=icon}
Site SearchRaleigh, N.C. — Visiclear Tablets, a colon cleansing product owned by Salix Pharmaceuticals, will go on sale in Japan on June 15.
Zeria Pharmaceutical of Tokyo licensed Visiclear from Salix. Zeria obtained rights to the drug in 2001 from InKine Pharmaceuticals, which Salix acquired in 2005.
The product is sold in the U.S. under the name Visicol.
The drug is used to prepare people for colonoscopy exams.
Salix Product Nears Market in Japan
Copyright 2009 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
News Alerts to your Email & Cell Phone-
- PC makers may face a legal challenge in ‘Green Dam’ battle from U.S. firm
Updated Jul. 3 7:42 a.m. - As Nortel’s final demise nears, what blame should its board shoulder?
Posted Jul. 3 7:03 a.m. - Climate change and the economy: Public policies like ‘cap and trade’ and a carbon tax could have big impacts on our wallets.
Posted Jul. 3 6:43 a.m. - 20/20: Surgery can let you see like a child again
Posted Jul. 3 6:29 a.m. |
- CDC: US swine flu cases rise to nearly 34,000
Updated Jul. 3 6:30 a.m.
- PC makers may face a legal challenge in ‘Green Dam’ battle from U.S. firm
-
- RTP-based Metabolon raises another $1 million in venture capital
Jul. 2, 2009 - NanoCor Therapeutics raises $2.5M
Jul. 1, 2009 - Despite three IPOs, venture-backed exits drop to trickle in second quarter
Jul. 1, 2009 - Seeking investors? Be sure to find the right angel partners
Jul. 1, 2009 - Georgia Research Alliance venture fund closes on $18.75 million
Jun. 29, 2009
- RTP-based Metabolon raises another $1 million in venture capital
More from wrallocaltechwire.com
Market Watch
advertisement